Fudan University Shanghai Medical College

What Fudan University Shanghai Medical College does

Fudan University Shanghai Medical College is a public medical education and research institution founded in 1927 as China's first national medical college established by Chinese nationals. Since the 2000 merger with Fudan University, it has operated as a tripartite co-constructed institution under China's Ministry of Education, National Health Commission, and Shanghai Municipality pursuant to a 2018 co-construction agreement. It serves medical students (undergraduate through postdoctoral), biomedical researchers, and a large patient population reached through a network of 18 affiliated hospitals. The institution's mandate spans medical training, basic and translational research, and clinical service delivery.

The college's research portfolio is organized around several translational platforms: the Brain Science Translation Research Institute, Basic-Clinical Integration platforms, and Gene/Cell Therapy initiatives. Recent outputs include peer-reviewed work on retinal prosthesis (published in Science, 2024) and microglia replacement (published in Science, 2025). Disclosed AI-adjacent capabilities include multi-agent AI for disease surveillance (in collaboration with Shanghai CDC), AI-empowered traditional Chinese medicine for chronic disease management launched as a 2026 National S&T major project at Huashan Hospital, computer vision for medical imaging, multi-omics integration, and internet hospital platforms that extend clinical reach.

The business model combines government appropriations (tripartite funding from education and health authorities plus the Shanghai municipal government), tuition, competitive national research grants (the Brain Science Translation Research Institute reportedly attracted 1.6 billion RMB over three years), clinical revenue generated through affiliated hospitals, and industry-funded joint laboratories. Commercial activity extends through paired assistance relationships with 69 partner institutions and selective international academic engagement, including a side event at the 79th World Health Assembly in 2025. Note: the entity is a public academic institution, not a commercial enterprise; standard PE/VC/M&A revenue mechanics do not apply directly.

Name

Fudan University Shanghai Medical College

Legal name

Fudan University Shanghai Medical College (复旦大学上海医学院)

Website

https://shmc.fudan.edu.cn

Company type

Private

Founded year

1927

Operating status

Operating

Short description

Fudan University Shanghai Medical College, founded in 1927 as China's first national medical college, provides medical education, biomedical research, and clinical services through 18 affiliated hospitals under tripartite Ministry of Education, National Health Commission, and Shanghai Municipality governance.

Ownership category

akta.pro rank

Product category

Medical Education and Biomedical Research

NAICS

Colleges, Universities, and Professional Schools (6113), Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000)

akta.pro primary industry

Medical Schools (MD/DO Granting) (EDAHAGAB)

akta.pro secondary industries

Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI), Schools of Nursing (EDAHAGAC), Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA)

Keywords

• Medical education
• Biomedical research
• Clinical medicine training
• Public health programs
• Affiliated hospital network

Headquarters

HQ city

Shanghai

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Others

Revenue model

1. Government Education Funding: As a national key university under the Ministry of Education, Fudan Shanghai Medical College receives government appropriations for education and research, including triple co-construction funding from the Ministry of Education, National Health Commission, and Shanghai Municipal Government.
2. Tuition and Fees: Revenue from domestic and international student tuition, including undergraduate, graduate, doctoral, and postdoctoral programs in medical and health sciences.
3. Research Grants and Contracts: Funding from national key R&D programs (e.g., 'Four Major Chronic Diseases' major special project), provincial/ministerial level research projects, and industry collaborative research.
4. Clinical Services Revenue: Revenue generated by affiliated hospitals (18 affiliated hospitals) through medical services, which support the medical education ecosystem.
5. Donations and Endowments: Donations from alumni, society, and corporate donors (e.g., Fosun Group, Aikang, Meiou Medical) through the 'Yan Fuqing Medical Education Development Fund' and special anniversary funds.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels9 records

Core offering

Fudan University Shanghai Medical College is a public academic medical institution that provides medical and health sciences education from undergraduate through postdoctoral levels, conducts cutting-edge biomedical and translational research, and delivers clinical care through a network of 18 affiliated hospitals. It is structured around undergraduate and graduate medical programs, central research institutes (brain science, oncology, gene therapy), and clinical services spanning all major medical specialties.

Product overview

Fudan University Shanghai Medical College (复旦大学上海医学院) operates as an integrated academic medical institution comprising: (1) A network of 18 affiliated hospitals providing comprehensive clinical services; (2) Medical education programs spanning undergraduate, graduate, and post-graduate training; (3) Centralized research platforms and instrumentation centers supporting biomedical research; (4) Digital health services including internet hospital platforms for telemedicine. The institution does not offer commercial software products but provides healthcare, education, and research services through its institutional infrastructure.

Differentiator

Problem solved

Functional benefit

Products and services

• Affiliated Hospital System (附属医院系统) A comprehensive network of 18 affiliated hospitals that deliver integrated medical services, research, and clinical education across all major specialties for patients across China.
• Medical Education Programs (医学教育体系) Undergraduate, graduate, international student, and postgraduate medical education programs in 7 national first-class disciplines including clinical medicine, basic medicine, stomatology, pharmacology, nursing, public health, and medical laboratory technology for students from China and abroad.
• Research Platforms and Instrumentation Center (科研平台与仪器平台) Centralized research instrumentation and platform services providing shared access to advanced scientific equipment, including gene sequencing facilities, for biomedical research across the institution's laboratories and affiliated research institutes.
• Internet Hospital Platform (互联网医院平台) Online consultation and telemedicine services enabling patients to access specialty medical care remotely through affiliated hospital internet platforms, including remote diagnostics, follow-up consultations, and digital prescription services.

Quantifiable outcome

• 15 medical science achievements awarded at 2021 Shanghai Medical Science and Technology Awards (first completion unit)
• +4 more outcomes

Named customers16 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature3 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Huashan Hospital / National Major S&T Program on AI-Enabled TCM (华山医院/四大慢病国家科技重大专项)coreStrategic or Co-development Partner · 26 June 2026Major national S&T special project on 'Four Major Chronic Diseases' launched at Huashan Hospital on June 26, 2026, focusing on AI-empowered Traditional Chinese Medicine for improving prognosis of non-surgical cerebral hemorrhage patients.
• Shanghai Hongzhimeng Biotechnology Co., Ltd. (上海宏之梦生物科技有限公司)minorStrategic or Co-development Partner · 11 June 2026School-enterprise joint laboratory for Black Bolete bio-pharmaceutical research and natural drug innovation, signed and inaugurated June 11, 2026 at Fudan Shanghai Medical College.
• Science Journal (《科学》/ Science Series Journals)coreStrategic or Co-development Partner · 23 October 2022Deepened cooperation between Fudan and Science journal series, promoting China's high-level research to the world. Science series journal Editor-in-Chief Holden Thorp visited June 8, 2022, with collaboration discussions.
• JAMA (American Medical Association Journal)coreStrategic or Co-development Partner · 23 October 2022JAMA editor-in-chief Kirsten Bibbins-Domingo visited Fudan Shanghai Medical College May 30, 2026, discussing collaboration and journal partnership.
• Shanghai (Nanxiang) Precision Medicine Industrial Park (上海(南翔)精准医学产业园)minorStrategic or Co-development Partner · 1 January 2022Precision medicine industrial park donated to support student education and scientific research achievement transformation at Fudan Shanghai Medical College.
• Chongqing Medical University (重庆医科大学)coreStrategic or Co-development Partner · 1 January 2022Deep historical ties from 1956 when 400+ Fudan Shanghai Medical faculty members established Chongqing Medical University. In 2022, Chongqing Medical University President Huang Ailong attended 95th anniversary events,泥土 from old campus returned to Fudan.
• Ministry of Education, National Health Commission, and Shanghai Government (教育部、国家卫生健康委、上海市)coreStrategic or Co-development Partner · 21 December 2018Triple co-construction and trusteeship agreement signed December 21, 2018, between Ministry of Education, National Health Commission, and Shanghai Government for co-building and trusteeship of Fudan Shanghai Medical College and its directly affiliated hospitals. This unique co-governance model provides policy advantages and integrated management of clinical and basic education.

Scale indicators15 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• Sichuan University West China School of Medicine: Top-tier western Chinese medical school with Hua Xi Hospital group; competes on research outputs (Nature/Science publications), affiliated hospital scale, and clinical reputation. Direct comparable peer in academic medicine.
• Tongji Medical College (HUST): Major public medical school under Huazhong University of Science and Technology in Wuhan with comparable affiliated hospital scale and biomedical research output. Directly comparable on education footprint and clinical network.
• Tsinghua University School of Medicine: Rising elite medical school leveraging Tsinghua's engineering and AI strengths for the "Medicine+X" interdisciplinary model, increasingly competing for talent, AI-medical research dollars, and top-tier Gaokao admits in direct overlap with FSMC's positioning.
• Nanjing Medical University: Strong public medical university in eastern China with comparable education programs and affiliated hospital network; competes for graduate and clinical research talent within the Yangtze River Delta region.
• Air Force Medical University (Fourth Military Medical University): Major military-affiliated medical university with comparable research scale, affiliated hospitals, and biomedical research output including gene therapy and brain research. Comparable peer in the elite-tier Chinese medical education segment.
• China Medical University: Major northeastern Chinese public medical university, comparable in clinical training infrastructure and medical education scale; competes for talent pipeline and clinical research funding.
• Sun Yat-sen University Zhongshan School of Medicine: Major southern China public medical school with comparable clinical training infrastructure (e.g., Sun Yat-sen Memorial Hospital) and competitive research positioning. Comparable scale and comparable access to national-level funding and academicians.
• Shanghai Jiao Tong University School of Medicine: Same-city peer medical school within Shanghai Jiao Tong University, with overlapping affiliated hospitals (Renji, Ruijin, Xinhua, etc.) and competing for talent, research funding, and clinical patient volumes in Shanghai. Directly comparable on education, research, and clinical dimensions.
• Zhejiang University School of Medicine: Top-tier Chinese public medical school, competitive on national rankings, affiliated hospital network, and biomedical research output. Direct peer for talent recruitment (Academician level) and national S&T program funding.
• Peking University Health Science Center: China's premier public medical university under Peking University, with comparable 8-year MD programs, academician talent density, and affiliated hospital network (e.g., Peking University People's Hospital). Direct competitor for top Gaokao recruits, research funding, and clinical reputation.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xweibo.com/u/2940483802
• Facebookfacebook.com/107337502622028
• LinkedInlinkedin.com/company/fudan-university

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fudan University Shanghai Medical College